Anomalous Self-Experience in First Episode Psychosis - A Six-Year Follow-Up Study
1 other identifier
observational
56
1 country
1
Brief Summary
The objective of this study is to explore the longitudinal course of self-disturbances (SD) in schizophrenia. The main aim of the study is to investigate, in a 6-7-year follow-up of a representative sample of patients with first-episode schizophrenia, bipolar disorder and other psychoses. The overall aim is to expand our knowledge about the role of SDs in psychotic disorders. Increased knowledge here will aid diagnosis and treatment. The current study is a seven year follow-up of this representative cohort, with baseline measures of SDs and a comprehensive clinical and neurocognitive assessment battery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 17, 2014
CompletedFirst Posted
Study publicly available on registry
December 22, 2014
CompletedStudy Start
First participant enrolled
February 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2016
CompletedApril 27, 2017
April 1, 2017
1.8 years
December 17, 2014
April 26, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Change From Baseline in EASE (Examination of Anomalous Self-Experience)Total Score and Subscales of EASE
6 year
Secondary Outcomes (1)
Change from Baseline for Structured Clinical Interview for the DSM ( SCID-I)(DSM-IV)
6 year
Other Outcomes (5)
Change From Baseline in Positive and negative syndrome
6 year
Change From Baseline in Calgary Depression Scale Score for Schizophrenia (CDSS)
6 year
Change from Baseline for Alcohol and Drug Use Disorder Identification Test (AUDIT and DUDIT)
6 year
- +2 more other outcomes
Study Arms (1)
Follow-Up Group
An earlier investigated cohort with first episode psychosis patients from two Norwegian counties. Being between 18 - 65 years old and being consecutive in- or outpatient referred to first adequate treatment for a DSM-IV diagnosis of schizophrenia, bipolar disorder, or "other psychosis".
Eligibility Criteria
Patients reffered to their first adequate treatment for broadly defines psychotic disorders (inkluding both schizophrenia - and bipolar Spectrum disorders) in Oppland and Hedmark counties in Norway, in 2008 - 2009 participated the base-line part of the study(E. Haug, 2012).
You may qualify if:
- Patients who participated and completed base-line part of the study,
- Patients with concurrent substance use disorder are included, but have to demonstrate at least one month without substance use, or clear signs that the psychotic disorder had started before the onset of significant substance use.
You may not qualify if:
- Patients with brain injury,
- Patients with on going substance use,
- Unable to provide informed consent statement.
- Not able to be interviewed.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sykehuset Innlandet HFlead
- Oslo University Hospitalcollaborator
Study Sites (1)
Sykehuset Innlandet HF
Brumunddal, 2380, Norway
Related Publications (5)
Haug E, Oie M, Andreassen OA, Bratlien U, Nelson B, Aas M, Moller P, Melle I. Anomalous self-experience and childhood trauma in first-episode schizophrenia. Compr Psychiatry. 2015 Jan;56:35-41. doi: 10.1016/j.comppsych.2014.10.005. Epub 2014 Oct 16.
PMID: 25458477BACKGROUNDHaug E, Oie M, Andreassen OA, Bratlien U, Raballo A, Nelson B, Moller P, Melle I. Anomalous self-experiences contribute independently to social dysfunction in the early phases of schizophrenia and psychotic bipolar disorder. Compr Psychiatry. 2014 Apr;55(3):475-82. doi: 10.1016/j.comppsych.2013.11.010. Epub 2013 Nov 28.
PMID: 24378241BACKGROUNDHaug E, Lien L, Raballo A, Bratlien U, Oie M, Andreassen OA, Melle I, Moller P. Selective aggregation of self-disorders in first-treatment DSM-IV schizophrenia spectrum disorders. J Nerv Ment Dis. 2012 Jul;200(7):632-6. doi: 10.1097/NMD.0b013e31825bfd6f.
PMID: 22759943BACKGROUNDHaug E, Oie M, Melle I, Andreassen OA, Raballo A, Bratlien U, Lien L, Moller P. The association between self-disorders and neurocognitive dysfunction in schizophrenia. Schizophr Res. 2012 Mar;135(1-3):79-83. doi: 10.1016/j.schres.2011.11.015. Epub 2011 Dec 3.
PMID: 22137461BACKGROUNDHaug E, Melle I, Andreassen OA, Raballo A, Bratlien U, Oie M, Lien L, Moller P. The association between anomalous self-experience and suicidality in first-episode schizophrenia seems mediated by depression. Compr Psychiatry. 2012 Jul;53(5):456-60. doi: 10.1016/j.comppsych.2011.07.005. Epub 2011 Aug 25.
PMID: 21871617BACKGROUND
Biospecimen
Blood tests including cardiovascular risk factors and immunological parameters (cytokines).
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 17, 2014
First Posted
December 22, 2014
Study Start
February 1, 2015
Primary Completion
December 1, 2016
Study Completion
December 1, 2016
Last Updated
April 27, 2017
Record last verified: 2017-04